311 related articles for article (PubMed ID: 12888590)
21. Monitoring human cytomegalovirus infection in transplant recipients.
Baldanti F; Lilleri D; Gerna G
J Clin Virol; 2008 Mar; 41(3):237-41. PubMed ID: 18203657
[TBL] [Abstract][Full Text] [Related]
22. Cytomegalovirus (CMV) resistance to antivirals.
Drew WL; Paya CV; Emery V
Am J Transplant; 2001 Nov; 1(4):307-12. PubMed ID: 12099372
[TBL] [Abstract][Full Text] [Related]
23. Treatment of ganciclovir-resistant human cytomegalovirus infection.
Grossi P; Baldanti F
J Nephrol; 1997; 10(3):146-51. PubMed ID: 9238622
[TBL] [Abstract][Full Text] [Related]
24. Drug resistance in cytomegalovirus: current knowledge and implications for patient management.
J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 12 Suppl 1():S1-22. PubMed ID: 8680897
[No Abstract] [Full Text] [Related]
25. The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo.
Kaptein SJ; Efferth T; Leis M; Rechter S; Auerochs S; Kalmer M; Bruggeman CA; Vink C; Stamminger T; Marschall M
Antiviral Res; 2006 Feb; 69(2):60-9. PubMed ID: 16325931
[TBL] [Abstract][Full Text] [Related]
26. Clinical relevance of cytomegalovirus infection in patients with disorders of the immune system.
Steininger C
Clin Microbiol Infect; 2007 Oct; 13(10):953-63. PubMed ID: 17803749
[TBL] [Abstract][Full Text] [Related]
27. Clinical aspects of cytomegalovirus antiviral resistance in solid organ transplant recipients.
Le Page AK; Jager MM; Iwasenko JM; Scott GM; Alain S; Rawlinson WD
Clin Infect Dis; 2013 Apr; 56(7):1018-29. PubMed ID: 23243176
[TBL] [Abstract][Full Text] [Related]
28. Antiviral drugs for cytomegalovirus diseases.
Biron KK
Antiviral Res; 2006 Sep; 71(2-3):154-63. PubMed ID: 16765457
[TBL] [Abstract][Full Text] [Related]
29. Cytomegalovirus (CMV) glycoprotein B genotypes and response to antiviral therapy, in solid-organ-transplant recipients with CMV disease.
Humar A; Kumar D; Gilbert C; Boivin G
J Infect Dis; 2003 Aug; 188(4):581-4. PubMed ID: 12898447
[TBL] [Abstract][Full Text] [Related]
30. [Cytomegalovirus sensitivity to anti-retroviral agents in patients infected with the human immunodeficiency virus with chorioretinitis in Spain].
Cañizares MA; Losada I; Pérez-Elías MJ; González J; Rubio R; Casado JL; Guerrero A
Enferm Infecc Microbiol Clin; 2001 Dec; 19(10):471-4. PubMed ID: 11844451
[TBL] [Abstract][Full Text] [Related]
31. Prophylaxis and treatment of cytomegalovirus disease in recipients of solid organ transplants: current approach and future challenges.
Puius YA; Snydman DR
Curr Opin Infect Dis; 2007 Aug; 20(4):419-24. PubMed ID: 17609603
[TBL] [Abstract][Full Text] [Related]
32. New inhibitors of human cytomegalovirus (HCMV) on the horizon.
De Clercq E
J Antimicrob Chemother; 2003 May; 51(5):1079-83. PubMed ID: 12697653
[No Abstract] [Full Text] [Related]
33. Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina.
Sánchez Puch S; Ochoa C; Carballal G; Zala C; Cahn P; Brunet R; Salomón H; Videla C
J Clin Virol; 2004 Jul; 30(3):271-5. PubMed ID: 15135748
[TBL] [Abstract][Full Text] [Related]
34. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients.
Nogueira E; Ozaki KS; Tomiyama H; Granato CF; Camara NO; Pacheco-Silva A
Int Immunopharmacol; 2006 Dec; 6(13-14):2031-7. PubMed ID: 17161359
[TBL] [Abstract][Full Text] [Related]
35. Monitoring transplant patients for human cytomegalovirus: Diagnostic update.
Gerna G; Lilleri D
Herpes; 2006 May; 13(1):4-11. PubMed ID: 16732996
[TBL] [Abstract][Full Text] [Related]
36. Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation.
Shapira MY; Resnick IB; Chou S; Neumann AU; Lurain NS; Stamminger T; Caplan O; Saleh N; Efferth T; Marschall M; Wolf DG
Clin Infect Dis; 2008 May; 46(9):1455-7. PubMed ID: 18419454
[TBL] [Abstract][Full Text] [Related]
37. Use of high-dose ganciclovir for a resistant cytomegalovirus infection due to UL97 mutation.
West P; Schmiedeskamp M; Neeley H; Oberholzer J; Benedetti E; Kaplan B
Transpl Infect Dis; 2008 Apr; 10(2):129-32. PubMed ID: 17605740
[TBL] [Abstract][Full Text] [Related]
38. Novel inhibitors of human CMV.
Andrei G; De Clercq E; Snoeck R
Curr Opin Investig Drugs; 2008 Feb; 9(2):132-45. PubMed ID: 18246516
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of cytomegalovirus DNAaemia versus pp65-antigenaemia cutoff for guiding preemptive therapy in transplant recipients: a randomized study.
Gerna G; Baldanti F; Torsellini M; Minoli L; Viganò M; Oggionnis T; Rampino T; Castiglioni B; Goglio A; Colledan M; Mammana C; Nozza F; Daniele L;
Antivir Ther; 2007; 12(1):63-72. PubMed ID: 17503749
[TBL] [Abstract][Full Text] [Related]
40. Viral monitoring and successful treatment of a ganciclovir-resistant cytomegalovirus infection in a heart transplant recipient.
García-Martínez J; Folgueira L; Delgado R; Hernando S; Prieto C; Aguado JM; Otero JR
Transpl Infect Dis; 2008 Apr; 10(2):123-8. PubMed ID: 17605746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
